Keyword: Pharma

News

Siegfried acquires Alliance Medical Products

31.05.2012 - Swiss contract manufacturer Siegfried has acquired Alliance Medical Products (AMP), based in Irvine, CA, USA for $58 million. This acquisition gives Siegfried, which is active in...

News

Valeant Withdraws Its Bid For ISTA Pharmaceuticals

30.01.2012 - Valeant Pharmaceuticals International said on Monday it has withdrawn its sweetened takeover bid for ISTA Pharmaceuticals, citing a lack of progress. "We were not interested in...

Plant Construction & Process Technology

What Pharma Can Learn from the Tobacco Industry

25.01.2012 - Billion-Dollar Industry - The illicit trade in counterfeit pharmaceuticals is worth an estimated $200 billion a year and has obvious implications for public health. A range of anti...

Plant Construction & Process Technology

Interoperability in the Pharma Supply Chain

25.01.2012 - Framework - When asked, most people say that they believe regulations should avoid dictating specific technologies but instead should dictate desired outcomes and let industry...

News

Saltigo Examines the State of Custom Manufacturing in the New Year

24.01.2012 - Optimism Springs Eternal - 2011 was a year fraught with uncertainties, and many industries are wearily eyeing the year to come. The state of the worldwide economy as well as the...

News

EU Agency Issues Guideline on Biosimilar MS Drugs

24.01.2012 - European regulators took another step towards opening the market for copies of biotech drugs on by releasing a draft guideline on how companies should test biosimilar medicines...

Plant Construction & Process Technology

Counterfeit Pharmaceuticals

24.01.2012 - The War Continues - The European Union's Falsified Medicines directive, ratified in 2011, was arguably the most significant landmark to date in the war on fake drugs. The law will...

News

Pharma Asks The Money Question Earlier For New Drugs

22.12.2011 - GlaxoSmithKline executive German Pasteris is in charge of an Alzheimer's treatment that is years from reaching the market, if it ever does. But he already wants to make sure the...